In the pursuit of personalized medicine, there is a growing demand for computational models with parameters that are easily obtainable to accelerate the development of potential solutions. Blood tests, owing to their affordability, accessibility, and routine use in healthcare, offer valuable biomarkers for assessing hemostatic balance in thrombotic and bleeding disorders. Incorporating these biomarkers into computational models of blood coagulation is crucial for creating patient-specific models, which allow for the analysis of the influence of these biomarkers on clot formation. This systematic review aims to examine how clinically relevant biomarkers are integrated into computational models of blood clot formation, thereby advancing discussions on integration methodologies, identifying current gaps, and recommending future research directions. A systematic review was conducted following the PRISMA protocol, focusing on ten clinically significant biomarkers associated with hemostatic disorders: D-dimer, fibrinogen, Von Willebrand factor, factor Ⅷ, P-selectin, prothrombin time (PT), activated partial thromboplastin time (APTT), antithrombin Ⅲ, protein C, and protein S. By utilizing this set of biomarkers, this review underscores their integration into computational models and emphasizes their integration in the context of venous thromboembolism and hemophilia. Eligibility criteria included mathematical models of thrombin generation, blood clotting, or fibrin formation under flow, incorporating at least one of these biomarkers. A total of 53 articles were included in this review. Results indicate that commonly used biomarkers such as D-dimer, PT, and APTT are rarely and superficially integrated into computational blood coagulation models. Additionally, the kinetic parameters governing the dynamics of blood clot formation demonstrated significant variability across studies, with discrepancies of up to 1, 000-fold. This review highlights a critical gap in the availability of computational models based on phenomenological or first-principles approaches that effectively incorporate affordable and routinely used clinical test results for predicting blood coagulation. This hinders the development of practical tools for clinical application, as current mathematical models often fail to consider precise, patient-specific values. This limitation is especially pronounced in patients with conditions such as hemophilia, protein C and S deficiencies, or antithrombin deficiency. Addressing these challenges by developing patient-specific models that account for kinetic variability is crucial for advancing personalized medicine in the field of hemostasis.
Citation: Mohamad Al Bannoud, Tiago Dias Martins, Silmara Aparecida de Lima Montalvão, Joyce Maria Annichino-Bizzacchi, Rubens Maciel Filho, Maria Regina Wolf Maciel. Integrating biomarkers for hemostatic disorders into computational models of blood clot formation: A systematic review[J]. Mathematical Biosciences and Engineering, 2024, 21(12): 7707-7739. doi: 10.3934/mbe.2024339
[1] | Jana Söderlund, Peter Newman . Biophilic architecture: a review of the rationale and outcomes. AIMS Environmental Science, 2015, 2(4): 950-969. doi: 10.3934/environsci.2015.4.950 |
[2] | Suprava Ranjan Laha, Binod Kumar Pattanayak, Saumendra Pattnaik . Advancement of Environmental Monitoring System Using IoT and Sensor: A Comprehensive Analysis. AIMS Environmental Science, 2022, 9(6): 771-800. doi: 10.3934/environsci.2022044 |
[3] | Michael R. Templeton, Acile S. Hammoud, Adrian P. Butler, Laura Braun, Julie-Anne Foucher, Johanna Grossmann, Moussa Boukari, Serigne Faye, Jean Patrice Jourda . Nitrate pollution of groundwater by pit latrines in developing countries. AIMS Environmental Science, 2015, 2(2): 302-313. doi: 10.3934/environsci.2015.2.302 |
[4] | Clare Maristela V. Galon, James G. Esguerra . Impact of COVID-19 on the environment sector: a case study of Central Visayas, Philippines. AIMS Environmental Science, 2022, 9(2): 106-121. doi: 10.3934/environsci.2022008 |
[5] | Doddabhimappa R. Gangapur, Parinita Agarwal, Pradeep K. Agarwal . Molecular markers for genetic diversity studies in Jatropha (Jatropha curcas L.). AIMS Environmental Science, 2018, 5(5): 340-352. doi: 10.3934/environsci.2018.5.340 |
[6] | Ernyasih, Anwar Mallongi, Anwar Daud, Sukri Palutturi, Stang, Abdul RazakThaha, Erniwati Ibrahim, Wesam Al Madhoun, Andriyani . Strategy for mitigating health and environmental risks from vehicle emissions in South Tangerang. AIMS Environmental Science, 2023, 10(6): 794-808. doi: 10.3934/environsci.2023043 |
[7] | Jirapa Wongsa, Ramita Liamchang, Neti Ngearnpat, Kritchaya Issakul . Cypermethrin insecticide residue, water quality and phytoplankton diversity in the lychee plantation catchment area. AIMS Environmental Science, 2023, 10(5): 609-627. doi: 10.3934/environsci.2023034 |
[8] | Muhammad Andang Novianta, Syafrudin, Budi Warsito, Siti Rachmawati . Monitoring river water quality through predictive modeling using artificial neural networks backpropagation. AIMS Environmental Science, 2024, 11(4): 649-664. doi: 10.3934/environsci.2024032 |
[9] | Francesco Teodori . Health physics calculation framework for environmental impact assessment of radiological contamination. AIMS Environmental Science, 2021, 8(4): 403-420. doi: 10.3934/environsci.2021026 |
[10] | Amir Hedayati Aghmashhadi, Giuseppe T. Cirella, Samaneh Zahedi, Azadeh Kazemi . Water resource policy support system of the Caspian Basin. AIMS Environmental Science, 2019, 6(4): 242-261. doi: 10.3934/environsci.2019.4.242 |
In the pursuit of personalized medicine, there is a growing demand for computational models with parameters that are easily obtainable to accelerate the development of potential solutions. Blood tests, owing to their affordability, accessibility, and routine use in healthcare, offer valuable biomarkers for assessing hemostatic balance in thrombotic and bleeding disorders. Incorporating these biomarkers into computational models of blood coagulation is crucial for creating patient-specific models, which allow for the analysis of the influence of these biomarkers on clot formation. This systematic review aims to examine how clinically relevant biomarkers are integrated into computational models of blood clot formation, thereby advancing discussions on integration methodologies, identifying current gaps, and recommending future research directions. A systematic review was conducted following the PRISMA protocol, focusing on ten clinically significant biomarkers associated with hemostatic disorders: D-dimer, fibrinogen, Von Willebrand factor, factor Ⅷ, P-selectin, prothrombin time (PT), activated partial thromboplastin time (APTT), antithrombin Ⅲ, protein C, and protein S. By utilizing this set of biomarkers, this review underscores their integration into computational models and emphasizes their integration in the context of venous thromboembolism and hemophilia. Eligibility criteria included mathematical models of thrombin generation, blood clotting, or fibrin formation under flow, incorporating at least one of these biomarkers. A total of 53 articles were included in this review. Results indicate that commonly used biomarkers such as D-dimer, PT, and APTT are rarely and superficially integrated into computational blood coagulation models. Additionally, the kinetic parameters governing the dynamics of blood clot formation demonstrated significant variability across studies, with discrepancies of up to 1, 000-fold. This review highlights a critical gap in the availability of computational models based on phenomenological or first-principles approaches that effectively incorporate affordable and routinely used clinical test results for predicting blood coagulation. This hinders the development of practical tools for clinical application, as current mathematical models often fail to consider precise, patient-specific values. This limitation is especially pronounced in patients with conditions such as hemophilia, protein C and S deficiencies, or antithrombin deficiency. Addressing these challenges by developing patient-specific models that account for kinetic variability is crucial for advancing personalized medicine in the field of hemostasis.
Human mitochondrial DNA (mtDNA) has proven to be a useful tool for a variety of anthropological investigations such as forensics genetics, human evolutionary history, migration patterns, and population studies [1,2,3,4,5]. Sequence diversity within the mitochondrial D-loop hypervariable regions (HVR1 and HVR2) has been applied for this purpose since the level of polymorphism in these regions is high enough to permit its use as an important tool in population diversity studies [6,7]. However, most of these studies are based on an analysis of a controlled cohort of individuals which are randomly selected to be representative of the population of the geographical region of interest [8,9]. In this study, we present an alternate approach for the analysis of population diversity by targeting human mtDNA directly from environmental waters impacted by human contamination.
DNA is naturally shed into the environment by virtually all animal species through feces, urine, exudates, or tissue residues [10,11]. There are numerous sources of human mtDNA in environmental waters. These include fecal waste from combined sewer overflows (CSO), sanitary sewer overflows, household sewage treatment systems, and agriculture/urban runoff [12,13]. Human fecal waste has been shown to have large amounts of exfoliated epithelial cells, each cell harboring thousands of mitochondrial copies making mtDNA an adequate molecular target in environmental studies. Recently, several studies have taken advantage of human-specific mtDNA signature sequences to implicate human feces as the primary source of contamination in fecally-contaminated effluents [14,15,16]. Consequently, human mtDNA sequences obtained from environmental waters are reliable, quantitative and real-time indicators of diversity of the contributing populations.
With the exception of one study, the aforementioned studies have focused on the detection of mtDNA using qPCR assays to detect fecal pollution sources. Recently, Kapoor et al. [13] demonstrated the use of mtDNA sequence analysis to both determine the importance of specific human fecal pollution sources in an urban watershed (Cincinnati, OH), as well as the relative abundance of population haplogroups associated with the contributing populations. We hypothesize that human mtDNA sequences in sewage are reliable, quantitative, and real-time indicators of population diversity in a community. To describe, characterize, and track human population diversity in a watershed region, we used high-throughput DNA sequencing technology to profile the HVR2 sequences in water samples taken from a tropical watershed (Río Grande de Arecibo (RGA), Puerto Rico) impacted by human sewage. Like previous controlled population studies [6,9], the single-nucleotide polymorphisms (SNPs) present in HVR2 was used to differentiate populations on the basis of their frequencies of occurrence. Furthermore, we extracted haplotypes and assigned mitochondrial haplogroups to identify the mtDNA biological ancestry of the populations impacting the watershed. We demonstrate the potential of these data for surveying the distribution of population diversity in this region and their intersection with orthogonal data like U.S. Census data. These data establish a regional-scale, baseline population profile, which represents a unique metagenomics tool for studying population diversity, regional migration, and other anthropological investigations.
The Río Grande de Arecibo (RGA) watershed is located along the western-central part of Puerto Rico and has a catchment area of approximately 769 km2, with water flowing northward from the central mountain range into a coastal valley before discharging into the Atlantic Ocean. Multiple point sources, including leaking septic and sewer systems and discharge from wastewater treatment plants (WWTPs) contribute to human fecal pollution in the watershed, in addition to several nonpoint sources associated with recreational activities. Three secondary sewage treatment plants discharge disinfected secondary effluents into the watershed: two drain into Río Cidra and Río Caunillas, tributaries of the RGA, while the third drains directly into the RGA. The water quality of the RGA watershed is a major concern as it is an important drinking water reservoir and some sections are used in recreational activities. Thus, fecal contamination of the RGA is a significant public health concern and has a negative economic impact. Most of the population in the RGA watershed is located in the coastal alluvial plain near the municipality of Arecibo [17]. The upper watershed is mostly forested, undeveloped land.
The sampling sites (Figure 1) were identified and assessed for the presence of human fecal contamination through PCR-based detection of human fecal markers as described in a previous study [18]. These sites had a high human density based on previously recorded fecal pollution levels and potential impact from human fecal pollution via sewage overflow and watershed runoff [18]. Three sites (4, 7, and 10) were located downstream of a wastewater treatment plant (WWTP) for the municipalities of Adjuntas, Utuado, and Jayuya, respectively. Sites 6 and 7 represent sites before and after a WWTP. Site 6 is located approximately 1.62 km upstream from site 7, and site 7 is located 120 m downstream from the sewage treatment plant. Site 8 is located at the mouth of the watershed right before the RGA drains into the Atlantic Ocean and close to the town center of Arecibo.
Ten samples (Table 1) were chosen from the water samples collected within the RGA watershed sites. The water samples collected within the RGA watershed represented different degrees of human contamination. Water sample collection and DNA extraction was performed as described earlier [18,19]. Briefly, all samples were collected using sterile bottles and transported on ice to the laboratory at the University of Puerto Rico—Río Piedras Campus where the samples (100 mL) were filtered through polycarbonate membranes (0.4-µm pore size, 47-mm diameter; GE Water and Process Technologies, Trevose, PA) and stored at −80 ℃ until DNA extraction. The membranes were shipped overnight on dry ice to the EPA laboratory (Cincinnati, OH) for DNA extraction. Total DNA was extracted from filters samples using the PowerSoil DNA isolation kit, following the manufacturer's instructions (Mo Bio Laboratories, Inc.). DNA extracts were stored at −20 ℃ until further processing.
Sample | Site | Sampling Date | Location | Presumed human contamination source |
1 | 7 | 6/10/2010 | Downstream from Utuado WWTP | Sewage |
2 | 7 | 10/28/2010 | Downstream from Utuado WWTP | Sewage |
3 | 7 | 5/27/2010 | Downstream from Utuado WWTP | Sewage |
4 | 8 | 11/12/2009 | Mouth of Arecibo River | Urban runoff, recreation |
5 | 8 | 9/23/2010 | Mouth of Arecibo River | Urban runoff, recreation |
6 | 8 | 10/24/2010 | Mouth of Arecibo River | Urban runoff, recreation |
7 | 4 | 11/23/2009 | Downstream from Adjuntas WWTP, Cidra River | Sewage |
8 | 4 | 5/27/2010 | Downstream from Adjuntas WWTP, Cidra River | Sewage |
9 | 6 | 10/28/2010 | Upstream from Utuado WWTP | Septic tanks |
10 | 10 | 11/12/2009 | Downstream from Jayuya WWTP | Sewage |
The human mitochondrial hypervariable region Ⅱ sequences were elucidated via Illumina sequencing of HVR2 libraries generated with DNA extracts and barcoded primers HVR2-F (5′-GGTCTATCACCCTATTAACCAC-3′) and HVR2-R (5′-CTGTTAAAAGTGCATACCGCC-3′) [13]. We generated PCR amplicon libraries for each water DNA extracts. PCR reactions were performed in 25 μL volumes using the Ex Taq kit (Takara) with 200 nM each of the forward and reverse primer and 2 μL of template DNA. Cycling conditions involved an initial 5 min denaturing step at 94 ℃, followed by 35 cycles of 45 s at 94 ℃, 60 s at 56 ℃, and 90 s at 72 ℃ and a final elongation step of 10 min at 72 ℃. Prior to multiplexed sequencing, PCR products were visualized on an agarose gel to confirm product sizes. Sequencing of the pooled library was performed on an Illumina Miseq benchtop sequencer using pair-end 250 bp kits at the Cincinnati Children's Hospital DNA Core facility. The HVRII sequence of the operator was also determined through Sanger sequencing and confirmed that it did not contribute to experimental data.
All HVR2 sequences were sorted according to barcodes and grouped under their respective sampling event. The sequences were processed and cleaned using the software MOTHUR v1.25.1 [20]. Briefly, fastq files for forward and reverse reads were used to form contigs which were first screened for sequence length (no greater than 420 bp). To compensate for potential sequencing errors, sequences having an average quality under 20, having ambiguous bases (Ns), or being shorter than 300 bp were discarded. The quality-filtered sequences were then aligned to the revised Cambridge Reference Sequence (rCRS) [21] for human mitochondrial DNA (NC_012920.1| Homo sapiens mitochondrion, complete genome); and analyzed by using custom scripts to detect the SNPs present in the sequences. All SNPs with frequency greater than 5% were used for further analyses. Additionally, the sequences were exported to CLC Genomics Workbench Version 6.5 (CLC Bio, Cambridge, MA) and aligned to the rCRS, after which the Quality-based Variant Detection was called to detect insertions and deletions (indels) as well as SNPs with reference to the rCRS as described previously [13]. The mitochondrial genome databases, including MITOMAP [22], mtDB [23] and Phylotree [24] were referred to validate the occurrence of detected variants. Haplotypes were extracted and submitted to MITOMASTER version Beta 1 [25] to assign mitochondrial haplogroups based on variants present in HVR2.
In total, more than 100, 000 sequence reads were retrieved with a mean output exceeding 20, 000 per barcoded sample, which were then filtered and grouped according to their respective sampling events. HVR2 DNA from ten samples was sequenced and screened producing an average read length of approximately 423 bp. Of this, a 300 bp portion (i.e., from base position 50 to 350) was used for variant detection since SNPs in this region have been well documented [22]. A total of 19 distinct variants were detected with frequency greater than 5% of the total number of unique reads, all of which are present in MITOMAP—database of mtDNA Control Region Sequence Variants [22]. We observed some SNPs that were common to all samples with varying frequencies, while other SNPs were sample-specific, allowing each sample to have a unique human mtDNA signature in the form SNP allelic frequencies (Figure 2). The variation in SNP frequencies could be the result of several factors including limited sample size, population changes related to migration, changes in sampling time and storm runoff volumes during wet weather events, or a combination of them. Variants 73G and 263G were detected in all samples with high frequency ( > 90%), while variant 150T was detected in all samples except the samples belonging to sites 4 and 8. Interestingly, variant 263G has been observed for mitochondrial genomes from European populations [26], and is compatible with the European ancestry that originated in the island over five centuries ago. All the variants detected at site 6 were also detected for samples belonging to site 7, except for 232G which was detected at site 6 with relatively low frequency. This is expected since sites 6 and 7 are located in close proximity to each other. Site 8 had two unique variants (67T, 81T) which may be attributed to the influx of water from several different tributaries, since site 8 is located right before the RGA drains into the Atlantic Ocean at sea level and it is the most downstream of all sampling sites.
Mitochondrial haplogroups have arisen from mutation and migration during human evolution and largely correspond to the geographic regions of their origin [23,24]. These mitochondrial haplogroups can be used to define ancestry based on the frequency of observation as a means of investigating population diversity [4,27]. For instance, there is broad correspondence between the L haplogroups and African ethnicity assignments, while the H haplogroups are most common among the Europeans. Consequently, we sought to use our human mtDNA sequences to extract haplotypes and classify them into haplogroups by comparing them to the Phylotree database [24]. We observed abundant diversity of haplotypes from HVR2 amplicons for all samples, which is consistent with the clear indication of human-associated pollution in the watershed [18]. The major haplotypes obtained from each sample are presented in Table 2.
Sample | Haplotype |
1 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 315.1C |
2 | 73G, 150T, 189G, 263G, 315.1C; 73G, 95G, 150T, 189G, 263G, 315.1C; 73G, 95G, 150T, 189G, 263G; 73G, 150T, 189G, 263G |
3 | 73G, 263G, 315.1C; 73G, 150T, 263G, 315.1C; 73G, 263G, 309.1C, 310C; 73G, 263G, 310C 73G, 143A, 195delT, 248delA, 263G, 286delAA, 309.2C, 310C |
4 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 173C, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |
5 | 73G, 263G, 309.1C, 310C; 73G, 263G, 310C; 73G, 263G, 315.1C; 73G, 81T, 263G, 309.1C, 310C; 73G, 263G, 309.1C; 73G, 263G; 73G, 309.1C, 310C |
6 | 73G, 263G, 315.1C; 73G, 263G, 388G; 67T, 73G, 263G, 315.1C; 73G, 176C, 263G, 315.1C; 73G, 263G |
7 | 73G, 263G, 315.1C; 73G, 263G, 309.1C, 310C; 73G, 263G, 308A, 315.1C; 73G, 263G, 310C; 73G, 263G |
8 | 73G, 263G, 315.1C; 73G, 263G |
9 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 232G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |
10 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |
The mitochondrial sequences were compared and assigned to haplogroups based on the differences in HVR2 sequence mutations with respect to the rCRS. Since most accurate haplogroup prediction is based on full mtDNA sequences, sequences were assigned to the closest haplogroup for which the HVR2 sequence contained all mutations that define the haplogroup. The most salient features of the haplogroup distribution (Figure 3) in the clustered sequences were the relatively high frequencies of haplogroup H (32%). This haplogroup is very common in Europe [28,29] and its presence in the mtDNA sequences from our study is in agreement with the presence of European population on the island. Other dominant haplogroups were T (25%), L (24%) and B (11%). As an additional verification step, HVR2 PCR products were cloned (TOPO TA Cloning Kit for Sequencing, Invitrogen, Carlsbad, CA) and 90 colonies were randomly picked and sent for Sanger sequencing. Nucleotide sequences were assembled and edited by using Sequencher 4.7 software (Gene Codes, Ann Arbor, MI) and analyzed for haplogroup prediction using MITOMASTER. Most of the sequences belonged to the haplogroup H (40%), followed by T (20%), L (12%) and B (10%). The results obtained with Sanger sequencing corresponded well with Illumina high-throughput sequencing supporting the reproducibility of the results by alternative sequencing methods.
To further explore the applicability of our HVR2-derived haplogroup data to local population diversity, several mitochondrial databases and studies were consulted to assign haplogroups to the general population groups found in Puerto Rico. We assigned haplogroups H, T and J to "West Eurasians"; haplogroup L to "Sub-Saharan African"; and haplogroup B to "American Indian" according to Martínez‐Cruzado et al. [30]. Based on the average distribution of HVR2-derived population groups, most mtDNA haplogroups were identified as of West Eurasian ancestry (57.6%), followed by those of African (23.9%) and American Indian (11%) ancestries (Figure 4). According to U.S. census data for 2010 [31], populations belonging to these groups live in and around the study area. Figure 5 presents the comparative analysis of the population data obtained through the two strategies— census data for population (by race) viz-a-viz the HVR2-derived population groups for three different locations in the watershed. There was a strong correlation between the federal census data and the mitochondrial haplogroups as an indicator of population composition (Pearson product-moment correlation coefficient, r = 0.9) demonstrating the suitability of human mitochondrial sequences to infer the population structure of the neighborhoods impacting the watershed.
While their relative abundance is different, the average census abundance patterns (White > African American > American Indian) are similar to our findings suggesting that the results correspond with the census data for population (by race). The mtDNA sequencing analysis suggests that American Indian ancestry is more prevalent than that the census data reports. Similarly, results from studies using HVR1 and other mtDNA-restriction profiles have also suggested that the presence of American Indian signals in Puerto Rico is more prevalent than previously considered [30], which is in agreement with our findings. The HVR2 motifs that are characteristic of the 'American Indian' haplogroups detected in this study are 73G, 143A and 263G (32) whereas Martínez‐Cruzado (30) used predetermined restriction motifs as defining markers, along with HVR1 sequences to resolve inconclusive results. The latter approach to define haplogroups is more exact since it is based on haplogroup-defining markers for the entire mtDNA and not only just HVR2. However, classification of haplogroups based on analysis of small mtDNA regions with maximal discriminative power is useful for environmental studies due to concerns related to DNA damage in the environment. This approach has proven useful in past anthropological studies involving analysis of Neanderthal-type specimen to sequence small regions (300–350 bp) of Neanderthal mtDNA [33,34]. Deducing population diversity from mtDNA sequences retrieved from waste streams may be more accurate than census data since these are limited to people who respond to surveys and are subject to misclassification of self-declared racial/ethnic background while waste streams are impacted by everyone connected to the public sewer system. However, it is also possible that certain groups are overrepresented using the current approach either because they disproportionately use the water resources, are not connected to the sewer pipelines (e.g., use of septic tanks) and/or live in close proximity to sampling sites than others. Signature sequences from areas impacted by leaky septic tanks and combined sewer overflows will also be reflected in these types of molecular surveys. While further studies are needed to better understand how all these different sources may impact haplogroup distribution, we suggest that the use of these methods could provide complementary information in epidemiological studies.
The overall bioinformatics strategy in this study included the following steps: (ⅰ) trim/clean sequencing reads and group them according to sites, (ⅱ) map sample specific reads to the rCRS, (ⅲ) annotate the mapped sequences to detect variants in HVR2 region, and (ⅳ) extract haplotypes from individual reads and assign haplogroups based on HVR2 sequence motifs. As reported here, next-generation sequencing technology of the mitochondrial hypervariable sequences enabled the identification of a great number of mtDNA variants and at varied allele frequencies. The methods used in our study for haplogrouping uses only HVR2 sequences which may result in coarse haplogroup assignments. Since most accurate haplogroup prediction is based on full mtDNA sequences, sequences were assigned to the closest haplogroup for which the HVR2 sequences contain all SNPs that define the haplogroup. We believe that future global sequencing efforts associated with distinct populations will provide improved phylogenetic resolution of the human mtDNA hypervariable regions as a tool for defining genetic ancestry. It has not escaped our attention that extending our technique to include other mtDNA regions and/or assembling full mitochondrial genomes through metagenomics approaches on a massively parallel scale would allow for tracking humans through public waste streams, thus ethical concerns remain an important consideration in future work.
Mitochondrial DNA analysis has been applied in several biomedical investigations of human evolution, for example, studies tracing the origin of modern humans or of certain human populations. In addition, mtDNA analysis is extremely effective in a forensic setting for the identification of criminals and victims of crimes or accidents. Although our study was confined to analysis of HVRII region of human mtDNA for samples collected in a limited number of geographic locations, it can be inferred that by targeting specific regions of mtDNA, we can estimate cancer rates, occurrence of diseases, and population diversity in watershed regions impacted by human contamination. Moreover, we envision that a similar approach could be used to study the population diversity of different animal species in natural settings, such as local versus migratory birds.
We investigated the occurrence of HVR2 allelic frequencies of human mtDNA derived from water samples taken within a fecally impacted tropical watershed. The SNPs within the human HVR2 sequences represented a unique molecular signature for evaluating anthropogenic site-specific inputs. We observed several HVR2 haplotypes linked to these samples, and used this haplogroup data to derive human population diversity within the different sites of the watershed. There was a strong correspondence between the demographic census data and the population composition based on mitochondrial haplogroups, demonstrating the suitability of human mitochondrial sequences to infer the population structure of the neighborhoods impacting the watershed. As the levels of human mtDNA is significantly high in point and non-point sources of fecal pollution, detecting mtDNA allelic signatures in environmental waters provides a unique approach for simultaneously studying fecal waste source tracking, human population diversity and other many anthropological investigations.
We would like to thank Mehdi Keddache for help in data analysis, and David Wendell for providing access to the CLC Genomics program. VK was supported by U. S. Environmental Protection Agency (EPA) via a post-doctoral appointment administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. EPA. The manuscript has been subjected to the EPA's peer review and has been approved as an EPA publication. Mention of trade names or commercial products does not constitute endorsement or recommendation by the EPA for use. The views expressed in this article are those of the authors and do not necessarily represent the views or policies of the U.S. EPA.
All authors declare no conflicts of interest in this paper.
[1] |
S. Z. Goldhaber, H. Bounameaux, Pulmonary embolism and deep vein thrombosis, Lancet (London, England), 379 (2012), 1835–1846. https://doi.org/10.1016/S0140-6736(11)61904-1 doi: 10.1016/S0140-6736(11)61904-1
![]() |
[2] |
G. E. Raskob, P. Angchaisuksiri, A. N. Blanco, H. Buller, A. Gallus, B. J. Hunt, et al., Thrombosis: a major contributor to global disease burden, Arterioscler. Thromb. Vasc. Biol., 34 (2014), 2363–2371. https://doi.org/10.1161/ATVBAHA.114.304488 doi: 10.1161/ATVBAHA.114.304488
![]() |
[3] |
D. Voci, U. Fedeli, I. T. Farmakis, L. Hobohm, K. Keller, L. Valerio, et al., Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from an Italian high-risk area, Thromb. Res., 212 (2022), 44–50. https://doi.org/10.1016/j.thromres.2022.02.008 doi: 10.1016/j.thromres.2022.02.008
![]() |
[4] |
I. Katsoularis, O. Fonseca-Rodríguez, P. Farrington, H. Jerndal, E. H. Lundevaller, M. Sund, et al., Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study, BMJ, 377 (2022). https://doi.org/10.1136/bmj-2021-069590 doi: 10.1136/bmj-2021-069590
![]() |
[5] |
T. N. Nguyen, M. M. Qureshi, P. Klein, H. Yamagami, M. Abdalkader, R. Mikulik, et al., Global impact of the COVID-19 pandemic on cerebral venous thrombosis and mortality, J. Stroke, 24 (2022), 256–265. https://doi.org/10.5853/jos.2022.00752 doi: 10.5853/jos.2022.00752
![]() |
[6] |
E. Berntorp, K. Fischer, D. P. Hart, M. E. Mancuso, D. Stephensen, A. D. Shapiro, et al., Haemophilia, Nat. Rev. Dis. Prim., 7 (2021), 45. https://doi.org/10.1038/s41572-021-00278-x doi: 10.1038/s41572-021-00278-x
![]() |
[7] |
K. G. Link, M. T. Stobb, M. G. Sorrells, M. Bortot, K. Ruegg, M. J. Manco‐Johnson, et al., A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A, J. Thromb. Haemost., 18 (2020), 306–317. https://doi.org/10.1111/jth.14653 doi: 10.1111/jth.14653
![]() |
[8] |
F. W. G. Leebeek, W. Miesbach, Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues, Blood, 138 (2021), 923–931. https://doi.org/10.1182/blood.2019003777 doi: 10.1182/blood.2019003777
![]() |
[9] |
S. S. G. Halfmann, N. Evangelatos, P. Schröder-Bäck, A. Brand, European healthcare systems readiness to shift from 'One-Size Fits All' to personalized medicine, Per. Med., 14 (2017), 63–74. https://doi.org/10.2217/pme-2016-0061 doi: 10.2217/pme-2016-0061
![]() |
[10] |
T. Behl, I. Kaur, A. Sehgal, S. Singh, A. Albarrati, M. Albratty, et al., The road to precision medicine: Eliminating the "One Size Fits All" approach in Alzheimer's disease, Biomed. Pharmacother., 153 (2022), 113337. https://doi.org/10.1016/j.biopha.2022.113337 doi: 10.1016/j.biopha.2022.113337
![]() |
[11] |
N. M. Hamdy, E. B. Basalious, M. G. El-Sisi, M. Nasr, A. M. Kabel, E. S. Nossier, et al., Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine, Curr. Med. Res. Opin., 40 (2024), 1–19. https://doi.org/10.1080/03007995.2024.2416985 doi: 10.1080/03007995.2024.2416985
![]() |
[12] |
G. Di Minno, E. Tremoli, Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine, Haematologica, 102 (2017), 411–418. https://doi.org/10.3324/haematol.2016.156000 doi: 10.3324/haematol.2016.156000
![]() |
[13] | D. L. Ornstein, Chapter 41 - Personalized medicine for disorders of hemostasis and thrombosis, in Diagnostic Molecular Pathology (eds. W. B. Coleman and G. J. Tsongalis), Academic Press, (2024), 643–653. https://doi.org/10.1016/B978-0-12-822824-1.00006-7 |
[14] |
S. Nagalla, P. F. Bray, Personalized medicine in thrombosis: back to the future, Blood, 127 (2016), 2665–2671. https://doi.org/10.1182/blood-2015-11-634832 doi: 10.1182/blood-2015-11-634832
![]() |
[15] |
R. J. S. Preston, J. M. O'Sullivan, Personalized approaches to the treatment of hemostatic disorders, Semin. Thromb. Hemostasis, 47 (2021), 117–119. https://doi.org/10.1055/s-0041-1723800 doi: 10.1055/s-0041-1723800
![]() |
[16] |
H. Al‐Samkari, W. Eng, A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies, J. Thromb. Haemost., 20 (2022), 1077–1088. https://doi.org/10.1111/jth.15715 doi: 10.1111/jth.15715
![]() |
[17] |
X. Delavenne, E. Ollier, A. Lienhart, Y. Dargaud, A new paradigm for personalized prophylaxis for patients with severe haemophilia A, Haemophilia, 26 (2020), 228–235. https://doi.org/10.1111/hae.13935 doi: 10.1111/hae.13935
![]() |
[18] |
L. H. Bukkems, L. L. F. G. Valke, W. Barteling, B. A. P. Laros-van Gorkom, N. M. A. Blijlevens, M. H. Cnossen, et al., Combining factor Ⅷ levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A, Br. J. Clin. Pharmacol., 88 (2022), 2757–2768. https://doi.org/10.1111/bcp.15185 doi: 10.1111/bcp.15185
![]() |
[19] |
N. Mackman, W. Bergmeier, G. A. Stouffer, J. I. Weitz, Therapeutic strategies for thrombosis: new targets and approaches, Nat. Rev. Drug. Discov., 19 (2020), 333–352. https://doi.org/10.1038/s41573-020-0061-0 doi: 10.1038/s41573-020-0061-0
![]() |
[20] |
P. S. Wells, R. Ihaddadene, A. Reilly, M. A. Forgie, Diagnosis of venous thromboembolism: 20 years of progress, Ann. Intern. Med., 168 (2018), 131–140. https://doi.org/10.7326/M17-0291 doi: 10.7326/M17-0291
![]() |
[21] |
F. Khan, T. Tritschler, S. R. Kahn, M. A. Rodger, Venous thromboembolism, Lancet (London, England), 398 (2021), 64–77. https://doi.org/10.1016/S0140-6736(20)32658-1 doi: 10.1016/S0140-6736(20)32658-1
![]() |
[22] |
T. D. Martins, S. D. Martins, S. Montalvão, M. Al Bannoud, G. Y. Ottaiano, L. Q. Silva, et al., Combining artificial neural networks and hematological data to diagnose Covid-19 infection in Brazilian population, Neural Comput. Appl., 36 (2024), 4387–4399. https://doi.org/10.1007/s00521-023-09312-3 doi: 10.1007/s00521-023-09312-3
![]() |
[23] |
T. D. Martins, R. Maciel-Filho, S. A. L. Montalvão, G. S. S. Gois, M. Al Bannoud, G. Y. Ottaiano, et al., Predicting mortality of cancer patients using artificial intelligence, patient data and blood tests, Neural Comput. Appl., 36 (2024), 15599–15616. https://doi.org/10.1007/s00521-024-09915-4 doi: 10.1007/s00521-024-09915-4
![]() |
[24] |
F. W. G. Leebeek, New developments in diagnosis and management of acquired hemophilia and acquired von willebrand syndrome, HemaSphere, 5 (2021). https://doi.org/10.1097/HS9.0000000000000586 doi: 10.1097/HS9.0000000000000586
![]() |
[25] |
F. Peyvandi, G. Kenet, I. Pekrul, R. K. Pruthi, P. Ramge, M. Spannagl, Laboratory testing in hemophilia: Impact of factor and non‐factor replacement therapy on coagulation assays, J. Thromb. Haemost., 18 (2020), 1242–1255. https://doi.org/10.1111/jth.14784 doi: 10.1111/jth.14784
![]() |
[26] |
B. Pezeshkpoor, J. Oldenburg, A. Pavlova, Insights into the molecular genetic of hemophilia A and hemophilia B: The relevance of genetic testing in routine clinical practice, Hamostaseologie, 42 (2022), 390–399. https://doi.org/10.1055/a-1945-9429 doi: 10.1055/a-1945-9429
![]() |
[27] |
A. H. Kristoffersen, E. Ajzner, D. Rogic, E. Y. Sozmen, P. Carraro, A. P. Faria, et al., Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries, Thromb. Res., 142 (2016), 1–7. https://doi.org/10.1016/j.thromres.2016.04.001 doi: 10.1016/j.thromres.2016.04.001
![]() |
[28] |
M. Kafeza, J. Shalhoub, N. Salooja, L. Bingham, K. Spagou, A. H. Davies, A systematic review of clinical prediction scores for deep vein thrombosis, Phlebology, 32 (2017), 516–531. https://doi.org/10.1177/0268355516678729 doi: 10.1177/0268355516678729
![]() |
[29] |
M. T. Greene, A. C. Spyropoulos, V. Chopra, P. J. Grant, S. Kaatz, S. J. Bernstein, et al., Validation of risk assessment models of venous thromboembolism in hospitalized medical patients, Am. J. Med., 129 (2016), 1001.e9–1001.e18. https://doi.org/10.1016/j.amjmed.2016.03.031 doi: 10.1016/j.amjmed.2016.03.031
![]() |
[30] |
P. C. Silveira, I. K. Ip, S. Z. Goldhaber, G. Piazza, C. B. Benson, R. Khorasani, Performance of wells score for deep vein thrombosis in the inpatient setting, JAMA Intern. Med., 175 (2015), 1112–1117. https://doi.org/10.1001/jamainternmed.2015.1687 doi: 10.1001/jamainternmed.2015.1687
![]() |
[31] |
M. Kafeza, J. Shalhoub, N. Salooja, L. Bingham, K. Spagou, A. H. Davies, A systematic review of clinical prediction scores for deep vein thrombosis, Phlebology, 32 (2016), 516–531. https://doi.org/10.1177/0268355516678729 doi: 10.1177/0268355516678729
![]() |
[32] |
I. Nichele, A. Tosetto, Scoring Systems for Estimating the Risk of Recurrent Venous Thromboembolism, Semin. Thromb. Hemost., 43 (2017), 493–499. https://doi.org/10.1055/s-0037-1602662 doi: 10.1055/s-0037-1602662
![]() |
[33] |
A. Muñoz, C. Ay, E. Grilz, S. López, C. Font, V. Pachón, et al., A clinical-genetic risk score for predicting cancer-associated venous thromboembolism: A development and validation study involving two independent prospective cohorts, J. Clin. Oncol., 41 (2023), 2911–2925. https://doi.org/10.1200/JCO.22.00255 doi: 10.1200/JCO.22.00255
![]() |
[34] |
F. Rodeghiero, A. Tosetto, T. Abshire, D. M. Arnold, B. Coller, P. James, et al., ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders, J. Thromb. Haemost., 8 (2010), 2063–2065. https://doi.org/10.1111/j.1538-7836.2010.03975.x doi: 10.1111/j.1538-7836.2010.03975.x
![]() |
[35] |
M. Borhany, N. Fatima, M. Abid, T. Shamsi, M. Othman, Application of the ISTH bleeding score in hemophilia, Transfus. Apher. Sci., 57 (2018), 556–560. https://doi.org/10.1016/j.transci.2018.06.003 doi: 10.1016/j.transci.2018.06.003
![]() |
[36] |
M. Khalifa, M. Albadawy, Artificial intelligence for clinical prediction: Exploring key domains and essential functions, Comput. Methods Programs Biomed. Updat., 5 (2024), 100148. https://doi.org/10.1016/j.cmpbup.2024.100148 doi: 10.1016/j.cmpbup.2024.100148
![]() |
[37] |
T. H. Tan, C. C. Hsu, C. J. Chen, S. L. Hsu, T. L. Liu, H. J. Lin, et al., Predicting outcomes in older ED patients with influenza in real time using a big data-driven and machine learning approach to the hospital information system, BMC Geriatr., 21 (2021), 280. https://doi.org/10.1186/s12877-021-02229-3 doi: 10.1186/s12877-021-02229-3
![]() |
[38] |
C. Guan, F. Ma, S. Chang, J. Zhang, Interpretable machine learning models for predicting venous thromboembolism in the intensive care unit: an analysis based on data from 207 centers, Crit. Care, 27 (2023), 406. https://doi.org/10.1186/s13054-023-04683-4 doi: 10.1186/s13054-023-04683-4
![]() |
[39] |
T. D. Martins, J. M. Annichino-Bizzacchi, A. V. C. Romano, R. Maciel Filho, Artificial neural networks for prediction of recurrent venous thromboembolism, Int. J. Med. Inform., 141 (2020), 104221. https://doi.org/10.1016/j.ijmedinf.2020.104221 doi: 10.1016/j.ijmedinf.2020.104221
![]() |
[40] |
I. Pabinger, C. Ay, Biomarkers and venous thromboembolism, Arter. Thromb. Vasc. Biol., 29 (2009), 332–336. https://doi.org/10.1161/ATVBAHA.108.182188 doi: 10.1161/ATVBAHA.108.182188
![]() |
[41] |
I. Pabinger, J. Thaler, C. Ay, Biomarkers for prediction of venous thromboembolism in cancer, Blood, 122 (2013), 2011–2018. https://doi.org/10.1182/blood-2013-04-460147 doi: 10.1182/blood-2013-04-460147
![]() |
[42] |
F. Galeano-Valle, L. Ordieres-Ortega, C. M. Oblitas, J. del-Toro-Cervera, L. Alvarez-Sala-Walther, P. Demelo-Rodríguez, Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: A narrative review, Int. J. Mol. Sci., 22 (2021), 2627. https://doi.org/10.3390/ijms22052627 doi: 10.3390/ijms22052627
![]() |
[43] |
B. Jacobs, A. Obi, T. Wakefield, Diagnostic biomarkers in venous thromboembolic disease, J. Vasc. Surg. Venous Lymphat. Disord., 4 (2016), 508–517. https://doi.org/10.1016/j.jvsv.2016.02.005 doi: 10.1016/j.jvsv.2016.02.005
![]() |
[44] |
M. A. Bannoud, B. P. Gomes, M. C. de S. P. Abdalla, M. V Freire, K. Andreola, T. D. Martins, et al., Mathematical modeling of drying kinetics of ground Açaí (Euterpe oleracea) kernel using artificial neural networks, Chem. Pap., 78 (2024), 1033–1054. https://doi.org/10.1007/s11696-023-03142-2 doi: 10.1007/s11696-023-03142-2
![]() |
[45] |
M. A. Bannoud, T. D. Martins, B. F. dos Santos, Control of a closed dry grinding circuit with ball mills using predictive control based on neural networks, Digit. Chem. Eng., 5 (2022), 100064. https://doi.org/10.1016/j.dche.2022.100064 doi: 10.1016/j.dche.2022.100064
![]() |
[46] |
J. Berg, K. Nyström, Data-driven discovery of PDEs in complex datasets, J. Comput. Phys., 384 (2019), 239–252. https://doi.org/10.1016/j.jcp.2019.01.036 doi: 10.1016/j.jcp.2019.01.036
![]() |
[47] |
L. Burzawa, L. Li, X. Wang, A. Buganza-Tepole, D. M. Umulis, Acceleration of PDE-based biological simulation through the development of neural network metamodels, Curr. Pathobiol. Rep., 8 (2020), 121–131. https://doi.org/10.1007/s40139-020-00216-8 doi: 10.1007/s40139-020-00216-8
![]() |
[48] |
M. A. Bannoud, C. A. M. da Silva, T. D. Martins, Applications of metaheuristic optimization algorithms in model predictive control for chemical engineering processes: A systematic review, Annu. Rev. Control., 58 (2024), 100973. https://doi.org/10.1016/j.arcontrol.2024.100973 doi: 10.1016/j.arcontrol.2024.100973
![]() |
[49] |
M. A. Bannoud, P. H. N. Ferreira, R. R. de Andrade, C. A. M. da Silva, Control of an integrated first and second-generation continuous alcoholic fermentation process with cell recycling using model predictive control, Chem. Eng. Commun., (2024), 1–24. https://doi.org/10.1080/00986445.2024.2417901 doi: 10.1080/00986445.2024.2417901
![]() |
[50] |
Y. Zhao, C. Li, X. Liu, R. Qian, R. Song, X. Chen, Patient-specific seizure prediction via adder network and supervised contrastive learning, IEEE Trans. Neural Syst. Rehabil. Eng., 30 (2022), 1536–1547. https://doi.org/10.1109/TNSRE.2022.3180155 doi: 10.1109/TNSRE.2022.3180155
![]() |
[51] |
K. Leiderman, S. S. Sindi, D. M. Monroe, A. L. Fogelson, K. B. Neeves, The art and science of building a computational model to understand hemostasis, Semin. Thromb. Hemost., 47 (2021), 129–138. https://doi.org/10.1055/s-0041-1722861 doi: 10.1055/s-0041-1722861
![]() |
[52] |
N. Ratto, A. Bouchnita, P. Chelle, M. Marion, M. Panteleev, D. Nechipurenko, et al., Patient-specific modelling of blood coagulation, Bull. Math. Biol., 83 (2021), 50. https://doi.org/10.1007/s11538-021-00890-8 doi: 10.1007/s11538-021-00890-8
![]() |
[53] |
R. Burghaus, K. Coboeken, T. Gaub, L. Kuepfer, A. Sensse, H.-U. Siegmund, et al., Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation, PLoS One, 6 (2011), e17626. https://doi.org/10.1371/journal.pone.0017626 doi: 10.1371/journal.pone.0017626
![]() |
[54] |
C. Watson, H. Saaid, V. Vedula, J. C. Cardenas, P. K. Henke, F. Nicoud, et al., Venous thromboembolism: Review of clinical challenges, biology, assessment, treatment, and modeling, Ann. Biomed. Eng., 52 (2024), 467–486. https://doi.org/10.1007/s10439-023-03390-z doi: 10.1007/s10439-023-03390-z
![]() |
[55] |
N. N. Ramli, S. Iberahim, N. H. M. Noor, Z. Zulkafli, T. M. T. M. Shihabuddin, M. H. Din, et al., Haemostasis and inflammatory parameters as potential diagnostic biomarkers for VTE in trauma-immobilized patients, Diagnostics (Basel), 13 (2023), 150. https://doi.org/10.3390/diagnostics13010150 doi: 10.3390/diagnostics13010150
![]() |
[56] |
L. G. R. Ferreira, R. C. Figueiredo, M. das Graças Carvalho, D. R. A. Rios, Thrombin generation assay as a biomarker of cardiovascular outcomes and mortality: A narrative review, Thromb. Res., 220 (2022), 107–115. https://doi.org/10.1016/j.thromres.2022.10.007 doi: 10.1016/j.thromres.2022.10.007
![]() |
[57] |
M. S. Edvardsen, K. Hindberg, E. S. Hansen, V. M. Morelli, T. Ueland, P. Aukrust, et al., Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism, Blood Adv., 5 (2021), 224–232. https://doi.org/10.1182/bloodadvances.2020003135 doi: 10.1182/bloodadvances.2020003135
![]() |
[58] |
L. Anghel, R. Sascău, R. Radu, C. Stătescu, From classical laboratory parameters to novel biomarkers for the diagnosis of venous thrombosis, Int. J. Mol. Sci., 21 (2020), 1920. https://doi.org/10.3390/ijms21061920 doi: 10.3390/ijms21061920
![]() |
[59] |
H. Y. Lim, C. O'Malley, G. Donnan, H. Nandurkar, P. Ho, A review of global coagulation assays — Is there a role in thrombosis risk prediction?, Thromb. Res., 179 (2019), 45–55. https://doi.org/10.1016/j.thromres.2019.04.033 doi: 10.1016/j.thromres.2019.04.033
![]() |
[60] |
H. Hou, Z. Ge, P. Ying, J. Dai, D. Shi, Z. Xu, et al., Biomarkers of deep venous thrombosis, J. Thromb. Thrombolysis., 34 (2012), 335–346. https://doi.org/10.1007/s11239-012-0721-y doi: 10.1007/s11239-012-0721-y
![]() |
[61] |
D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med., 6 (2009), e1000097. https://doi.org/10.1371/journal.pmed.1000097 doi: 10.1371/journal.pmed.1000097
![]() |
[62] |
M. J. Page, J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372 (2021), n71. https://doi.org/10.1136/bmj.n71 doi: 10.1136/bmj.n71
![]() |
[63] |
E. N. Sorensen, G. W. Burgreen, W. R. Wagner, J. F. Antaki, Computational simulation of platelet deposition and activation: I. Model development and properties, Ann. Biomed. Eng., 27 (1999), 436–448. https://doi.org/10.1114/1.200 doi: 10.1114/1.200
![]() |
[64] |
K. Boryczko, W. Dzwinel, D. A. Yuen, Modeling fibrin aggregation in blood flow with discrete-particles, Comput. Methods Programs Biomed., 75 (2004), 181–194. https://doi.org/10.1016/j.cmpb.2004.02.001 doi: 10.1016/j.cmpb.2004.02.001
![]() |
[65] |
I. V. Pivkin, P. D. Richardson, G. Karniadakis, Blood flow velocity effects and role of activation delay time on growth and form of platelet thrombi, Proc. Natl. Acad. Sci. USA, 103 (2006), 17164–17169. https://doi.org/10.1073/pnas.0608546103 doi: 10.1073/pnas.0608546103
![]() |
[66] |
Z. Xu, N. Chen, M. M. Kamocka, E. D. Rosen, M. Alber, A multiscale model of thrombus development, J. R. Soc. Interface, 5 (2008), 705–722. https://doi.org/10.1098/rsif.2007.1202 doi: 10.1098/rsif.2007.1202
![]() |
[67] |
Z. Xu, N. Chen, S. C. Shadden, J. E. Marsden, M. M. Kamocka, E. D. Rosen, et al., Study of blood flow impact on growth of thrombi using a multiscale model, Soft. Matter, 5 (2009), 769–779. https://doi.org/10.1039/B812429A doi: 10.1039/B812429A
![]() |
[68] |
Z. Xu, J. Lioi, J. Mu, M. M. Kamocka, X. Liu, D. Z. Chen, et al., A multiscale model of venous thrombus formation with surface-mediated control of blood coagulation cascade, Biophys. J., 98 (2010), 1723–1732. https://doi.org/10.1016/j.bpj.2009.12.4331 doi: 10.1016/j.bpj.2009.12.4331
![]() |
[69] |
A. M. Shibeko, E. S. Lobanova, M. A. Panteleev, F. I. Ataullakhanov, Blood flow controls coagulation onset via the positive feedback of factor Ⅶ activation by factor Xa, BMC Syst. Biol., 4 (2010), 5. https://doi.org/10.1186/1752-0509-4-5 doi: 10.1186/1752-0509-4-5
![]() |
[70] |
S. W. Jordan, E. L. Chaikof, Simulated surface-induced thrombin generation in a flow field, Biophys. J., 101 (2011), 276–286. https://doi.org/10.1016/j.bpj.2011.05.056 doi: 10.1016/j.bpj.2011.05.056
![]() |
[71] |
K. Leiderman, A. L. Fogelson, Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flow, Math. Med. Biol., 28 (2011), 47–84. https://doi.org/10.1093/imammb/dqq005 doi: 10.1093/imammb/dqq005
![]() |
[72] |
A. L. Fogelson, Y. H. Hussain, K. Leiderman, Blood clot formation under flow: The importance of factor XI depends strongly on platelet count, Biophys. J., 102 (2012), 10–18. https://doi.org/10.1016/j.bpj.2011.10.048 doi: 10.1016/j.bpj.2011.10.048
![]() |
[73] |
K. Leiderman, A. L. Fogelson, The influence of hindered transport on the development of platelet thrombi under flow, Bull. Math. Biol., 75 (2013), 1255–1283. https://doi.org/10.1007/s11538-012-9784-3 doi: 10.1007/s11538-012-9784-3
![]() |
[74] |
A. Tosenberger, F. Ataullakhanov, N. Bessonov, M. Panteleev, A. Tokarev, V. Volpert, Modelling of thrombus growth in flow with a DPD-PDE method, J. Theor. Biol., 337 (2013), 30–41. https://doi.org/10.1016/j.jtbi.2013.07.023 doi: 10.1016/j.jtbi.2013.07.023
![]() |
[75] |
A. Sequeira, T. Bodnár, Blood coagulation simulations using a viscoelastic model, Math. Model. Nat. Phenom., 9 (2014), 34–45. https://doi.org/10.1051/mmnp/20149604 doi: 10.1051/mmnp/20149604
![]() |
[76] |
A. Tosenberger, N. Bessonov, V. Volpert, Influence of fibrinogen deficiency on clot formation in flow by hybrid model, Math. Model. Nat. Phenom., 10 (2015), 36–47. https://doi.org/10.1051/mmnp/201510102 doi: 10.1051/mmnp/201510102
![]() |
[77] |
O. S. Rukhlenko, O. A. Dudchenko, K. E. Zlobina, G. T. Guria, Mathematical modeling of intravascular blood coagulation under wall shear stress, PLoS One, 10 (2015), e0134028. https://doi.org/10.1371/journal.pone.0134028 doi: 10.1371/journal.pone.0134028
![]() |
[78] |
J. Pavlova, A. Fasano, J. Janela, A. Sequeira, Numerical validation of a synthetic cell-based model of blood coagulation, J. Theor. Biol., 380 (2015), 367–379. https://doi.org/10.1016/j.jtbi.2015.06.004 doi: 10.1016/j.jtbi.2015.06.004
![]() |
[79] |
A. Piebalgs, X. Y. Xu, Towards a multi-physics modelling framework for thrombolysis under the influence of blood flow, J. R. Soc. Interface, 12 (2015), 20150949. https://doi.org/10.1098/rsif.2015.0949 doi: 10.1098/rsif.2015.0949
![]() |
[80] |
Z. Li, A. Yazdani, A. Tartakovsky, G. E. Karniadakis, Transport dissipative particle dynamics model for mesoscopic advection-diffusion-reaction problems, J. Chem. Phys., 143 (2015), 14101. https://doi.org/10.1063/1.4923254 doi: 10.1063/1.4923254
![]() |
[81] |
A. Bouchnita, K. Bouzaachane, T. Galochkina, P. Kurbatova, P. Nony, V. Volpert, An individualized blood coagulation model to predict INR therapeutic range during warfarin treatment, Math. Model. Nat. Phenom., 11 (2016), 28–44. https://doi.org/10.1051/mmnp/201611603 doi: 10.1051/mmnp/201611603
![]() |
[82] |
J. H. Seo, T. Abd, R. T. George, R. Mittal, A coupled chemo-fluidic computational model for thrombogenesis in infarcted left ventricles, Am. J. Physiol. Heart Circ. Physiol., 310 (2016), H1567–82. https://doi.org/10.1152/ajpheart.00855.2015 doi: 10.1152/ajpheart.00855.2015
![]() |
[83] |
M. N. Ngoepe, Y. Ventikos, Computational modelling of clot development in patient-specific cerebral aneurysm cases, J. Thromb. Haemost., 14 (2016), 262–272. https://doi.org/10.1111/jth.13220 doi: 10.1111/jth.13220
![]() |
[84] |
A. Bouchnita, T. Galochkina, V. Volpert, Influence of antithrombin on the regimes of blood coagulation: Insights from the mathematical model, Acta Biotheor., 64 (2016), 327–342. https://doi.org/10.1007/s10441-016-9291-2 doi: 10.1007/s10441-016-9291-2
![]() |
[85] |
E. V. Dydek, E. L. Chaikof, Simulated thrombin generation in the presence of surface-bound heparin and circulating tissue factor, Ann. Biomed. Eng., 44 (2016), 1072–1084. https://doi.org/10.1007/s10439-015-1377-5 doi: 10.1007/s10439-015-1377-5
![]() |
[86] |
J. Pavlova, A. Fasano, A. Sequeira, Numerical simulations of a reduced model for blood coagulation, Zeitschrift für Angew. Math. und Phys., 67 (2016), 28. https://doi.org/10.1007/s00033-015-0610-2 doi: 10.1007/s00033-015-0610-2
![]() |
[87] |
A. Tosenberger, F. Ataullakhanov, N. Bessonov, M. Panteleev, A. Tokarev, V. Volpert, Modelling of platelet-fibrin clot formation in flow with a DPD-PDE method, J. Math. Biol., 72 (2016), 649–681. https://doi.org/10.1007/s00285-015-0891-2 doi: 10.1007/s00285-015-0891-2
![]() |
[88] |
V. Govindarajan, V. Rakesh, J. Reifman, A. Y. Mitrophanov, Computational study of thrombus formation and clotting factor effects under venous flow conditions, Biophys. J., 110 (2016), 1869–1885. https://doi.org/10.1016/j.bpj.2016.03.010 doi: 10.1016/j.bpj.2016.03.010
![]() |
[89] |
C. Ou, W. Huang, M. M.-F. Yuen, A computational model based on fibrin accumulation for the prediction of stasis thrombosis following flow-diverting treatment in cerebral aneurysms, Med. Biol. Eng. Comput., 55 (2017), 89–99. https://doi.org/10.1007/s11517-016-1501-1 doi: 10.1007/s11517-016-1501-1
![]() |
[90] |
A. Yazdani, H. Li, J. D. Humphrey, G. E. Karniadakis, A general shear-dependent model for thrombus formation, PLoS Comput. Biol., 13 (2017), e1005291. https://doi.org/10.1371/journal.pcbi.1005291 doi: 10.1371/journal.pcbi.1005291
![]() |
[91] |
H. Hosseinzadegan, D. K. Tafti, Prediction of thrombus growth: Effect of stenosis and reynolds number, Cardiovasc. Eng. Technol., 8 (2017), 164–181. https://doi.org/10.1007/s13239-017-0304-3 doi: 10.1007/s13239-017-0304-3
![]() |
[92] |
L. M. Haynes, T. Orfeo, K. G. Mann, S. J. Everse, K. E. Brummel-Ziedins, Probing the dynamics of clot-bound thrombin at venous shear rates, Biophys. J., 112 (2017), 1634–1644. https://doi.org/10.1016/j.bpj.2017.03.002 doi: 10.1016/j.bpj.2017.03.002
![]() |
[93] |
H. Kamada, Y. Imai, M. Nakamura, T. Ishikawa, T. Yamaguchi, Shear-induced platelet aggregation and distribution of thrombogenesis at stenotic vessels, Microcirculation, 24 (2017). https://doi.org/10.1111/micc.12355 doi: 10.1111/micc.12355
![]() |
[94] |
J. D. Horn, D. J. Maitland, J. Hartman, J. M. Ortega, A computational thrombus formation model: application to an idealized two-dimensional aneurysm treated with bare metal coils, Biomech. Model. Mechanobiol., 17 (2018), 1821–1838. https://doi.org/10.1007/s10237-018-1059-y doi: 10.1007/s10237-018-1059-y
![]() |
[95] |
R. Méndez Rojano, S. Mendez, F. Nicoud, Introducing the pro-coagulant contact system in the numerical assessment of device-related thrombosis, Biomech. Model. Mechanobiol., 17 (2018), 815–826. https://doi.org/10.1007/s10237-017-0994-3 doi: 10.1007/s10237-017-0994-3
![]() |
[96] |
B. Gu, A. Piebalgs, Y. Huang, C. Longstaff, A. D. Hughes, R. Chen, et al., Mathematical modelling of intravenous thrombolysis in acute ischaemic stroke: Effects of dose regimens on levels of fibrinolytic proteins and clot lysis time, Pharmaceutics, 11 (2019), 111. https://doi.org/10.3390/pharmaceutics11030111 doi: 10.3390/pharmaceutics11030111
![]() |
[97] |
K. Ayabe, S. Goto, H. Oka, H. Yabushita, M. Nakayama, A. Tomita, et al., Potential different impact of inhibition of thrombin function and thrombin generation rate for the growth of thrombi formed at site of endothelial injury under blood flow condition, Thromb. Res., 179 (2019), 121–127. https://doi.org/10.1016/j.thromres.2019.05.007 doi: 10.1016/j.thromres.2019.05.007
![]() |
[98] |
J. Chen, S. L. Diamond, Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ'-fibrin and factor XIa, PLoS Comput. Biol., 15 (2019), e1007266. https://doi.org/10.1371/journal.pcbi.1007266 doi: 10.1371/journal.pcbi.1007266
![]() |
[99] |
A. Bouchnita, V. Volpert, A multiscale model of platelet-fibrin thrombus growth in the flow, Comput. Fluids, 184 (2019), 10–20. https://doi.org/10.1016/j.compfluid.2019.03.021 doi: 10.1016/j.compfluid.2019.03.021
![]() |
[100] |
H. Hosseinzadegan, D. K. Tafti, A predictive model of thrombus growth in stenosed vessels with dynamic geometries, J. Med. Biol. Eng., 39 (2019), 605–621. https://doi.org/10.1007/s40846-018-0443-5 doi: 10.1007/s40846-018-0443-5
![]() |
[101] |
O. E. Kadri, V. D. Chandran, M. Surblyte, R. S. Voronov, In vivo measurement of blood clot mechanics from computational fluid dynamics based on intravital microscopy images, Comput. Biol. Med., 106 (2019), 1–11. https://doi.org/10.1016/j.compbiomed.2019.01.001 doi: 10.1016/j.compbiomed.2019.01.001
![]() |
[102] |
J. Du, D. Kim, G. Alhawael, D. N. Ku, A. L. Fogelson, Clot permeability, agonist transport, and platelet binding kinetics in arterial thrombosis, Biophys. J., 119 (2020), 2102–2115. https://doi.org/10.1016/j.bpj.2020.08.041 doi: 10.1016/j.bpj.2020.08.041
![]() |
[103] |
W. T. Wu, M. Zhussupbekov, N. Aubry, J. F. Antaki, M. Massoudi, Simulation of thrombosis in a stenotic microchannel: The effects of vWF-enhanced shear activation of platelets, Int. J. Eng. Sci., 147 (2020), 103206. https://doi.org/10.1016/j.ijengsci.2019.103206 doi: 10.1016/j.ijengsci.2019.103206
![]() |
[104] |
A. Bouchnita, K. Terekhov, P. Nony, Y. Vassilevski, V. Volpert, A mathematical model to quantify the effects of platelet count, shear rate, and injury size on the initiation of blood coagulation under venous flow conditions, PLoS One, 15 (2020), e0235392. https://doi.org/10.1371/journal.pone.0235392 doi: 10.1371/journal.pone.0235392
![]() |
[105] |
Z. L. Liu, D. N. Ku, C. K. Aidun, Mechanobiology of shear-induced platelet aggregation leading to occlusive arterial thrombosis: A multiscale in silico analysis, J. Biomech., 120 (2021), 110349. https://doi.org/10.1016/j.jbiomech.2021.110349 doi: 10.1016/j.jbiomech.2021.110349
![]() |
[106] |
V. N. Kaneva, J. L. Dunster, V. Volpert, F. Ataullahanov, M. A. Panteleev, D. Y. Nechipurenko, Modeling thrombus shell: Linking adhesion receptor properties and macroscopic dynamics, Biophys. J., 120 (2021), 334–351. https://doi.org/10.1016/j.bpj.2020.10.049 doi: 10.1016/j.bpj.2020.10.049
![]() |
[107] |
A. Yazdani, Y. Deng, H. Li, E. Javadi, Z. Li, S. Jamali, et al., Integrating blood cell mechanics, platelet adhesive dynamics and coagulation cascade for modelling thrombus formation in normal and diabetic blood, J. R. Soc. Interface., 18 (2021), 20200834. https://doi.org/10.1098/rsif.2020.0834 doi: 10.1098/rsif.2020.0834
![]() |
[108] |
C. Ma, Y. Ren, Q. Zheng, J. Wang, A computational model on cartesian adaptive grid for thrombosis simulation, IEEE Access, 10 (2022), 67694–67702. https://doi.org/10.1109/ACCESS.2022.3184123 doi: 10.1109/ACCESS.2022.3184123
![]() |
[109] |
R. Méndez Rojano, A. Lai, M. Zhussupbekov, G. W. Burgreen, K. Cook, J. F. Antaki, A fibrin enhanced thrombosis model for medical devices operating at low shear regimes or large surface areas, PLoS Comput. Biol., 18 (2022), e1010277. https://doi.org/10.1371/journal.pcbi.1010277 doi: 10.1371/journal.pcbi.1010277
![]() |
[110] |
M. Rezaeimoghaddam, F. N. van de Vosse, Continuum modeling of thrombus formation and growth under different shear rates, J. Biomech., 132 (2022), 110915. https://doi.org/10.1016/j.jbiomech.2021.110915 doi: 10.1016/j.jbiomech.2021.110915
![]() |
[111] | A. S. Pisaryuk, N. M. Povalyaev, A. V Poletaev, A. M. Shibeko, Systems biology approach for personalized hemostasis correction, J. Pers. Med., 12 (2022). https://doi.org/10.3390/jpm12111903 |
[112] |
M. Zhussupbekov, R. Méndez Rojano, W. T. Wu, J. F. Antaki, von Willebrand factor unfolding mediates platelet deposition in a model of high-shear thrombosis, Biophys. J., 121 (2022), 4033–4047. https://doi.org/10.1016/j.bpj.2022.09.040 doi: 10.1016/j.bpj.2022.09.040
![]() |
[113] |
Y. Wang, J. Luan, K. Luo, T. Zhu, J. Fan, Multi-constituent simulation of thrombosis in aortic dissection, Int. J. Eng. Sci., 184 (2023), 103817. http://dx.doi.org/10.1016/j.ijengsci.2023.103817 doi: 10.1016/j.ijengsci.2023.103817
![]() |
[114] |
R. Petkantchin, A. Rousseau, O. Eker, K. Zouaoui Boudjeltia, F. Raynaud, B. Chopard, A simplified mesoscale 3D model for characterizing fibrinolysis under flow conditions, Sci. Rep., 13 (2023), 13681. https://doi.org/10.1038/s41598-023-40973-1 doi: 10.1038/s41598-023-40973-1
![]() |
[115] |
K. Miyazawa, A. L. Fogelson, K. Leiderman, Inhibition of platelet-surface-bound proteins during coagulation under flow Ⅱ: Antithrombin and heparin, Biophys. J., 122 (2023), 230–240. https://doi.org/10.1016/j.bpj.2022.10.038 doi: 10.1016/j.bpj.2022.10.038
![]() |
[116] |
A. R. Rezaie, S. T. Olson, Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex: Demonstration by rapid kinetics studies, Biochemistry, 39 (2000), 12083–12090. https://doi.org/10.1021/bi0011126 doi: 10.1021/bi0011126
![]() |
[117] |
M. Anand, K. Rajagopal, K. R. Rajagopal, A model for the formation, growth, and lysis of clots in quiescent plasma: A comparison between the effects of antithrombin Ⅲ deficiency and protein C deficiency, J. Theor. Biol., 253 (2008), 725–738. https://doi.org/10.1016/j.jtbi.2008.04.015 doi: 10.1016/j.jtbi.2008.04.015
![]() |
[118] | M. J. Griffith, The heparin-enhanced antithrombin Ⅲ/thrombin reaction is saturable with respect to both thrombin and antithrombin Ⅲ, J. Biol. Chem., 257 (1982), 13302–13899. |
[119] | M. J. Griffith, Kinetics of the heparin-enhanced antithrombin Ⅲ/thrombin reaction. Evidence for a template model for the mechanism of action of heparin, J. Biol. Chem., 257 (1982), 7360–7365. |
[120] |
C. M. Danforth, T. Orfeo, K. G. Mann, K. E. Brummel-Ziedins, S. J. Everse, The impact of uncertainty in a blood coagulation model, Math. Med. Biol., 26 (2009), 323–336. https://doi.org/10.1093/imammb/dqp011 doi: 10.1093/imammb/dqp011
![]() |
[121] |
P. P. Naidu, M. Anand, Importance of Ⅷa inactivation in a mathematical model for the formation, growth, and lysis of clots, Math. Model. Nat. Phenom., 9 (2014), 17–33. https://doi.org/10.1051/mmnp/20149603 doi: 10.1051/mmnp/20149603
![]() |
[122] |
F. Saitta, J. Masuri, M. Signorelli, S. Bertini, A. Bisio, D. Fessas, Thermodynamic insights on the effects of low-molecular-weight heparins on antithrombin Ⅲ, Thermochim. Acta, 713 (2022), 179248. https://doi.org/10.1016/j.tca.2022.179248 doi: 10.1016/j.tca.2022.179248
![]() |
[123] |
H. Minakami, M. Morikawa, T. Yamada, T. Yamada, Candidates for the determination of antithrombin activity in pregnant women, J. Perinat. Med., 39 (2011), 369–374. https://doi.org/10.1515/jpm.2011.026 doi: 10.1515/jpm.2011.026
![]() |
[124] | K. C. Jones, K. G. Mann, A model for the tissue factor pathway to thrombin. Ⅱ: A mathematical simulation, J. Biol. Chem., 269 (1994), 23367–23373. |
[125] |
M. F. Hockin, K. C. Jones, S. J. Everse, K. G. Mann, A model for the stoichiometric regulation of blood coagulation, J. Biol. Chem., 277 (2002), 18322–18333. https://doi.org/10.1074/jbc.m201173200 doi: 10.1074/jbc.m201173200
![]() |
[126] |
R. Méndez Rojano, S. Mendez, D. Lucor, A. Ranc, M. Giansily-Blaizot, J. F. Schved, et al., Kinetics of the coagulation cascade including the contact activation system: sensitivity analysis and model reduction, Biomech. Model. Mechanobiol., 18 (2019), 1139–1153. https://doi.org/10.1007/s10237-019-01134-4 doi: 10.1007/s10237-019-01134-4
![]() |
[127] |
M. S. Chatterjee, W. S. Denney, H. Jing, S. L. Diamond, Systems biology of coagulation initiation: Kinetics of thrombin generation in resting and activated human blood, PLOS Comput. Biol., 6 (2010), e1000950. https://doi.org/10.1371/journal.pcbi.1000950 doi: 10.1371/journal.pcbi.1000950
![]() |
[128] |
A. Ranc, S. Bru, S. Mendez, M. Giansily-Blaizot, F. Nicoud, R. Méndez Rojano, Critical evaluation of kinetic schemes for coagulation, PLoS One, 18 (2023), e0290531. https://doi.org/10.1371/journal.pone.0290531 doi: 10.1371/journal.pone.0290531
![]() |
[129] |
M. F. Hockin, K. C. Jones, S. J. Everse, K. G. Mann, A model for the stoichiometric regulation of blood coagulation, J. Biol. Chem., 277 (2002), 18322–18333. https://doi.org/10.1074/jbc.m201173200 doi: 10.1074/jbc.m201173200
![]() |
[130] |
D. Luan, M. Zai, J. D. Varner, Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies, PLoS Comput. Biol., 3 (2007), 1347–1359. https://doi.org/10.1371/journal.pcbi.0030142 doi: 10.1371/journal.pcbi.0030142
![]() |
[131] |
K. G. Link, M. T. Stobb, J. Di Paola, K. B. Neeves, A. L. Fogelson, S. S. Sindi, et al., A local and global sensitivity analysis of a mathematical model of coagulation and platelet deposition under flow, PLoS One, 13 (2018), e0200917. https://doi.org/10.1371/journal.pone.0200917 doi: 10.1371/journal.pone.0200917
![]() |
![]() |
![]() |
1. | A. B. M. Tanvir Pasha, Jessica Hinojosa, Duc Phan, Adrianne Lopez, Vikram Kapoor, Detection of human fecal pollution in environmental waters using human mitochondrial DNA and correlation with general and human-associated fecal genetic markers, 2020, 18, 1477-8920, 8, 10.2166/wh.2019.197 | |
2. | Vikram Kapoor, Indrani Gupta, A. B. M. Tanvir Pasha, Duc Phan, Real-Time Quantitative PCR Measurements of Fecal Indicator Bacteria and Human-Associated Source Tracking Markers in a Texas River following Hurricane Harvey, 2018, 5, 2328-8930, 322, 10.1021/acs.estlett.8b00237 | |
3. | Jiayin Liang, Xiangqun Zheng, Tianyang Ning, Jiarui Wang, Xiaocheng Wei, Lu Tan, Feng Shen, Revealing the Viable Microbial Community of Biofilm in a Sewage Treatment System Using Propidium Monoazide Combined with Real-Time PCR and Metagenomics, 2024, 12, 2076-2607, 1508, 10.3390/microorganisms12081508 |
Sample | Site | Sampling Date | Location | Presumed human contamination source |
1 | 7 | 6/10/2010 | Downstream from Utuado WWTP | Sewage |
2 | 7 | 10/28/2010 | Downstream from Utuado WWTP | Sewage |
3 | 7 | 5/27/2010 | Downstream from Utuado WWTP | Sewage |
4 | 8 | 11/12/2009 | Mouth of Arecibo River | Urban runoff, recreation |
5 | 8 | 9/23/2010 | Mouth of Arecibo River | Urban runoff, recreation |
6 | 8 | 10/24/2010 | Mouth of Arecibo River | Urban runoff, recreation |
7 | 4 | 11/23/2009 | Downstream from Adjuntas WWTP, Cidra River | Sewage |
8 | 4 | 5/27/2010 | Downstream from Adjuntas WWTP, Cidra River | Sewage |
9 | 6 | 10/28/2010 | Upstream from Utuado WWTP | Septic tanks |
10 | 10 | 11/12/2009 | Downstream from Jayuya WWTP | Sewage |
Sample | Haplotype |
1 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 315.1C |
2 | 73G, 150T, 189G, 263G, 315.1C; 73G, 95G, 150T, 189G, 263G, 315.1C; 73G, 95G, 150T, 189G, 263G; 73G, 150T, 189G, 263G |
3 | 73G, 263G, 315.1C; 73G, 150T, 263G, 315.1C; 73G, 263G, 309.1C, 310C; 73G, 263G, 310C 73G, 143A, 195delT, 248delA, 263G, 286delAA, 309.2C, 310C |
4 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 173C, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |
5 | 73G, 263G, 309.1C, 310C; 73G, 263G, 310C; 73G, 263G, 315.1C; 73G, 81T, 263G, 309.1C, 310C; 73G, 263G, 309.1C; 73G, 263G; 73G, 309.1C, 310C |
6 | 73G, 263G, 315.1C; 73G, 263G, 388G; 67T, 73G, 263G, 315.1C; 73G, 176C, 263G, 315.1C; 73G, 263G |
7 | 73G, 263G, 315.1C; 73G, 263G, 309.1C, 310C; 73G, 263G, 308A, 315.1C; 73G, 263G, 310C; 73G, 263G |
8 | 73G, 263G, 315.1C; 73G, 263G |
9 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 232G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |
10 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |
Sample | Site | Sampling Date | Location | Presumed human contamination source |
1 | 7 | 6/10/2010 | Downstream from Utuado WWTP | Sewage |
2 | 7 | 10/28/2010 | Downstream from Utuado WWTP | Sewage |
3 | 7 | 5/27/2010 | Downstream from Utuado WWTP | Sewage |
4 | 8 | 11/12/2009 | Mouth of Arecibo River | Urban runoff, recreation |
5 | 8 | 9/23/2010 | Mouth of Arecibo River | Urban runoff, recreation |
6 | 8 | 10/24/2010 | Mouth of Arecibo River | Urban runoff, recreation |
7 | 4 | 11/23/2009 | Downstream from Adjuntas WWTP, Cidra River | Sewage |
8 | 4 | 5/27/2010 | Downstream from Adjuntas WWTP, Cidra River | Sewage |
9 | 6 | 10/28/2010 | Upstream from Utuado WWTP | Septic tanks |
10 | 10 | 11/12/2009 | Downstream from Jayuya WWTP | Sewage |
Sample | Haplotype |
1 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 315.1C |
2 | 73G, 150T, 189G, 263G, 315.1C; 73G, 95G, 150T, 189G, 263G, 315.1C; 73G, 95G, 150T, 189G, 263G; 73G, 150T, 189G, 263G |
3 | 73G, 263G, 315.1C; 73G, 150T, 263G, 315.1C; 73G, 263G, 309.1C, 310C; 73G, 263G, 310C 73G, 143A, 195delT, 248delA, 263G, 286delAA, 309.2C, 310C |
4 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 173C, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |
5 | 73G, 263G, 309.1C, 310C; 73G, 263G, 310C; 73G, 263G, 315.1C; 73G, 81T, 263G, 309.1C, 310C; 73G, 263G, 309.1C; 73G, 263G; 73G, 309.1C, 310C |
6 | 73G, 263G, 315.1C; 73G, 263G, 388G; 67T, 73G, 263G, 315.1C; 73G, 176C, 263G, 315.1C; 73G, 263G |
7 | 73G, 263G, 315.1C; 73G, 263G, 309.1C, 310C; 73G, 263G, 308A, 315.1C; 73G, 263G, 310C; 73G, 263G |
8 | 73G, 263G, 315.1C; 73G, 263G |
9 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 232G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |
10 | 73G, 150T, 263G, 315.1C; 73G, 150T, 189G, 263G, 315.1C; 73G, 150T, 176C, 263G, 315.1C; 73G, 150T, 176C, 189G, 263G, 315.1C; 73G, 150T, 263G; 73G, 150T, 189G, 263G |